Lataa...
Prevalence of Factor H–Binding Protein Variants and NadA among Meningococcal Group B Isolates from the United States: Implications for the Development of a Multicomponent Group B Vaccine
BACKGROUND: Two promising recombinant meningococcal protein vaccines are in development. One contains factor H–binding protein (fHBP) variants (v.) 1 and 2, whereas the other contains v.1 and 4 other antigens discovered by genome mining (5 component [5C]). Antibodies against fHBP are bactericidal ag...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2245893/ https://ncbi.nlm.nih.gov/pubmed/17436227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/514821 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|